TRF2 抗体
(Telomeric Repeat Binding Factor 2 (TERF2))
This gene encodes a telomere specific protein, TERF2, which is a component of the telomere nucleoprotein complex. This protein is present at telomeres in metaphase of the cell cycle, is a second negative regulator of telomere length and plays a key role in the protective activity of telomeres. While having similar telomere binding activity and domain organization, TERF2 differs from TERF1 in that its N terminus is basic rather than acidic. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| TRF2 抗体 (AA 324-500) | 人 | 小鼠 Monoclonal |
|
|
|
| TRF2 抗体 | 人, 小鼠, 大鼠, Deer | 小鼠 Monoclonal |
|
|
|
| TRF2 抗体 (AA 78-238) | 人 | 兔 Polyclonal |
|
|
|
| TRF2 抗体 (AA 144-438) | 人 | 兔 Polyclonal |
|
|
|
| TRF2 抗体 (AA 308-337) | 人 | 兔 Polyclonal |
|
|
|
| TRF2 抗体 | 人, 小鼠 | 山羊 Polyclonal |
|
|
|
| TRF2 抗体 (C-Term) | 人, 小鼠, 大鼠, 犬, Cow, 豚鼠, 马, 兔, 猴, Pig, 非洲爪蟾, Bat | 兔 Polyclonal |
|
|
|
| TRF2 抗体 (C-Term) | 人, 小鼠, 大鼠, 犬, Cow, 非洲爪蟾 | 兔 Polyclonal |
|
|
|
| TRF2 抗体 (AA 1-251) | 人 | 小鼠 Polyclonal |
|
|
|
| TRF2 抗体 (AA 81-287) | 人, 大鼠 | 兔 Polyclonal |
|
|
|
| Rockland Original | TRF2 抗体 | 人 | 小鼠 Monoclonal |
|
|
| TRF2 抗体 (AA 130-210) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| TRF2 抗体 (AA 375-425) | 人, 犬, Pig | 兔 Polyclonal |
|
|
|
| TRF2 抗体 (AA 308-337) (PE) | 人 | 兔 Polyclonal |
|
|
|
| TRF2 抗体 (AA 308-337) (APC) | 人 | 兔 Polyclonal |
|
|
|
| TRF2 抗体 (AA 324-500) | 人 | 小鼠 Monoclonal |
|
|
|
| TRF2 抗体 (AA 308-337) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| TRF2 抗体 (AA 78-238) | 人 | 山羊 Polyclonal |
|
|
|
| TRF2 抗体 (AA 308-337) | 人 | 兔 Polyclonal |
|
|
|
| TRF2 抗体 (C-Term) | 小鼠 | 兔 Polyclonal |
|
|
Primary Antibody
- ELISA (ELISA: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 有验证图片)
2 references - 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 3H6B4
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 324-500
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人, 小鼠, 大鼠, Deer
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 4A794-15
- 标记
- unconjugated
- 抗体亚型
- IgG1 kappa
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 78-238
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ICC (Immunocytochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 144-438
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB33900
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 308-337
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- ChIP (Chromatin Immunoprecipitation: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 小鼠, 大鼠, 犬, Cow, 非洲爪蟾
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-251
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 人, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 81-287
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- ELISA (ELISA: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ChIP (Chromatin Immunoprecipitation: 所列应用)
- FM (Fluorescence Microscopy: 所列应用)
- Supplier Product No.
- Rockland 200-301-i34
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 4A794-15
- 标记
- unconjugated
- 抗体亚型
- IgG1 kappa
Rockland Original
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 130-210
Primary Antibody
- WB (Western Blotting: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- PLA (Proximity Ligation Assay: 所列应用)
- 适用
- 人, 犬, Pig
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 375-425
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 308-337
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 308-337
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 3H6B4
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 324-500
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 308-337
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 78-238
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 308-337
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Latest Publications for our TRF2 抗体
: "TRF2 controls telomeric nucleosome organization in a cell cycle phase-dependent manner." in: PLoS ONE, Vol. 7, Issue 4, pp. e34386, (2012) (PubMed).
: "Elevated TRF2 in advanced breast cancers with short telomeres." in: Breast cancer research and treatment, Vol. 127, Issue 3, pp. 623-30, (2011) (PubMed).
: "The telomeric protein TRF2 is critical for the protection of A549 cells from both telomere erosion and DNA double-strand breaks driven by salvicine." in: Molecular pharmacology, Vol. 73, Issue 3, pp. 824-32, (2008) (PubMed).
: "Telomere elongation by a mutant tankyrase 1 without TRF1 poly(ADP-ribosyl)ation." in: Experimental cell research, Vol. 314, Issue 5, pp. 1115-24, (2008) (PubMed).
: "Telomere protection by mammalian Pot1 requires interaction with Tpp1." in: Nature structural & molecular biology, Vol. 14, Issue 8, pp. 754-61, (2007) (PubMed).
: "Apollo, an Artemis-related nuclease, interacts with TRF2 and protects human telomeres in S phase." in: Current biology : CB, Vol. 16, Issue 13, pp. 1295-302, (2006) (PubMed).
: "TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells." in: European journal of cancer (Oxford, England : 1990), Vol. 42, Issue 12, pp. 1881-8, (2006) (PubMed).
: "Changes in lamina structure are followed by spatial reorganization of heterochromatic regions in caspase-8-activated human mesenchymal stem cells." in: Journal of cell science, Vol. 119, Issue Pt 20, pp. 4247-56, (2006) (PubMed).
: "FLASH is required for histone transcription and S-phase progression." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, Issue 40, pp. 14808-12, (2006) (PubMed).
: "MDC1 accelerates nonhomologous end-joining of dysfunctional telomeres." in: Genes & development, Vol. 20, Issue 23, pp. 3238-43, (2006) (PubMed).
: "Elevated TRF2 in advanced breast cancers with short telomeres." in: Breast cancer research and treatment, Vol. 127, Issue 3, pp. 623-30, (2011) (PubMed).
: "The telomeric protein TRF2 is critical for the protection of A549 cells from both telomere erosion and DNA double-strand breaks driven by salvicine." in: Molecular pharmacology, Vol. 73, Issue 3, pp. 824-32, (2008) (PubMed).
: "Telomere elongation by a mutant tankyrase 1 without TRF1 poly(ADP-ribosyl)ation." in: Experimental cell research, Vol. 314, Issue 5, pp. 1115-24, (2008) (PubMed).
: "Telomere protection by mammalian Pot1 requires interaction with Tpp1." in: Nature structural & molecular biology, Vol. 14, Issue 8, pp. 754-61, (2007) (PubMed).
: "Apollo, an Artemis-related nuclease, interacts with TRF2 and protects human telomeres in S phase." in: Current biology : CB, Vol. 16, Issue 13, pp. 1295-302, (2006) (PubMed).
: "TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells." in: European journal of cancer (Oxford, England : 1990), Vol. 42, Issue 12, pp. 1881-8, (2006) (PubMed).
: "Changes in lamina structure are followed by spatial reorganization of heterochromatic regions in caspase-8-activated human mesenchymal stem cells." in: Journal of cell science, Vol. 119, Issue Pt 20, pp. 4247-56, (2006) (PubMed).
: "FLASH is required for histone transcription and S-phase progression." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, Issue 40, pp. 14808-12, (2006) (PubMed).
: "MDC1 accelerates nonhomologous end-joining of dysfunctional telomeres." in: Genes & development, Vol. 20, Issue 23, pp. 3238-43, (2006) (PubMed).
Aliases for TRF2 抗体
telomeric repeat binding factor 2 (TERF2) 抗体telomeric repeat binding factor 2 (Terf2) 抗体
telomeric repeat binding factor 2 L homeolog (terf2.L) 抗体
TERF2 抗体
TRBF2 抗体
TRF2 抗体
trf2 抗体
您还需要查找其他产品吗？
You are here:
